|
GB1479268A
(en)
*
|
1973-07-05 |
1977-07-13 |
Beecham Group Ltd |
Pharmaceutical compositions
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
CH596313A5
(enExample)
|
1975-05-30 |
1978-03-15 |
Battelle Memorial Institute |
|
|
US4385260A
(en)
*
|
1975-09-09 |
1983-05-24 |
Beckman Instruments, Inc. |
Bargraph display
|
|
US4414147A
(en)
|
1981-04-17 |
1983-11-08 |
Massachusetts Institute Of Technology |
Methods of decreasing the hydrophobicity of fibroblast and other interferons
|
|
JPS57206622A
(en)
|
1981-06-10 |
1982-12-18 |
Ajinomoto Co Inc |
Blood substitute
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4438253A
(en)
|
1982-11-12 |
1984-03-20 |
American Cyanamid Company |
Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US4565653A
(en)
*
|
1984-03-30 |
1986-01-21 |
Pfizer Inc. |
Acyltripeptide immunostimulants
|
|
US4879236A
(en)
*
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
AU5864086A
(en)
|
1985-04-22 |
1986-11-18 |
Genetics Institute Inc. |
High yield production of active factor ix
|
|
DE3676670D1
(de)
|
1985-06-26 |
1991-02-07 |
Cetus Corp |
Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung.
|
|
US5206344A
(en)
*
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
JPS6238172A
(ja)
|
1985-08-12 |
1987-02-19 |
株式会社 高研 |
抗血栓性医用材料の製造方法
|
|
IT1213029B
(it)
*
|
1986-01-30 |
1989-12-07 |
Bracco Ind Chimica Spa |
Chelati di ioni metallici paramagnetici.
|
|
US4925796A
(en)
*
|
1986-03-07 |
1990-05-15 |
Massachusetts Institute Of Technology |
Method for enhancing glycoprotein stability
|
|
EP0272253A4
(en)
|
1986-03-07 |
1990-02-05 |
Massachusetts Inst Technology |
METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
|
|
DK323587D0
(da)
|
1987-06-25 |
1987-06-25 |
Novo Industri As |
Protein
|
|
IL82834A
(en)
*
|
1987-06-09 |
1990-11-05 |
Yissum Res Dev Co |
Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
|
|
US4904584A
(en)
*
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
US5153265A
(en)
*
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
US4847325A
(en)
*
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
GB8810808D0
(en)
*
|
1988-05-06 |
1988-06-08 |
Wellcome Found |
Vectors
|
|
US5169933A
(en)
*
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
|
FR2638643B1
(fr)
|
1988-11-09 |
1991-04-12 |
Transgene Sa |
Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants
|
|
US5104651A
(en)
*
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
|
US5047335A
(en)
*
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
JP2989002B2
(ja)
*
|
1988-12-22 |
1999-12-13 |
キリン―アムジエン・インコーポレーテツド |
化学修飾顆粒球コロニー刺激因子
|
|
US6166183A
(en)
|
1992-11-30 |
2000-12-26 |
Kirin-Amgen, Inc. |
Chemically-modified G-CSF
|
|
US5194376A
(en)
*
|
1989-02-28 |
1993-03-16 |
University Of Ottawa |
Baculovirus expression system capable of producing foreign gene proteins at high levels
|
|
WO1990013540A1
(en)
|
1989-04-19 |
1990-11-15 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
US5324844A
(en)
*
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
US5166322A
(en)
*
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
US5342940A
(en)
|
1989-05-27 |
1994-08-30 |
Sumitomo Pharmaceuticals Company, Limited |
Polyethylene glycol derivatives, process for preparing the same
|
|
US5527527A
(en)
*
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
US5154924A
(en)
*
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
US5182107A
(en)
*
|
1989-09-07 |
1993-01-26 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
|
US5672683A
(en)
*
|
1989-09-07 |
1997-09-30 |
Alkermes, Inc. |
Transferrin neuropharmaceutical agent fusion protein
|
|
US5977307A
(en)
*
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
|
US5032519A
(en)
*
|
1989-10-24 |
1991-07-16 |
The Regents Of The Univ. Of California |
Method for producing secretable glycosyltransferases and other Golgi processing enzymes
|
|
US5580560A
(en)
*
|
1989-11-13 |
1996-12-03 |
Novo Nordisk A/S |
Modified factor VII/VIIa
|
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
|
IL96477A0
(en)
*
|
1989-12-01 |
1991-08-16 |
Amgen Inc |
Megakaryocyte production
|
|
CA2074839C
(en)
|
1990-01-29 |
2000-11-14 |
Kathleen L. Berkner |
Modified factor vii anticoagulant proteins
|
|
US5324663A
(en)
*
|
1990-02-14 |
1994-06-28 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
|
US5595900A
(en)
*
|
1990-02-14 |
1997-01-21 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
|
DE4009630C2
(de)
*
|
1990-03-26 |
1995-09-28 |
Reinhard Prof Dr Dr Brossmer |
CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
|
|
US5583042A
(en)
*
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
US5951972A
(en)
*
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
|
US5399345A
(en)
*
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
|
US5219564A
(en)
*
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
|
DK0538300T3
(da)
|
1990-07-10 |
1994-10-10 |
Boehringer Ingelheim Int |
O-Glycosyleret IFN-alfa
|
|
JP3051145B2
(ja)
|
1990-08-28 |
2000-06-12 |
住友製薬株式会社 |
新規なポリエチレングリコール誘導体修飾ペプチド
|
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
US5529914A
(en)
*
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
|
CA2073511A1
(en)
*
|
1990-11-14 |
1992-05-29 |
Matthew R. Callstrom |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
|
US5997864A
(en)
*
|
1995-06-07 |
1999-12-07 |
Novo Nordisk A/S |
Modified factor VII
|
|
US5861374A
(en)
*
|
1991-02-28 |
1999-01-19 |
Novo Nordisk A/S |
Modified Factor VII
|
|
ATE193551T1
(de)
|
1991-03-18 |
2000-06-15 |
Scripps Research Inst |
Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
|
|
US5212075A
(en)
|
1991-04-15 |
1993-05-18 |
The Regents Of The University Of California |
Compositions and methods for introducing effectors to pathogens and cells
|
|
US5506107A
(en)
|
1991-05-10 |
1996-04-09 |
Genentech, Inc. |
Selecting ligand agonists and antagonists
|
|
US5352670A
(en)
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
|
US5374655A
(en)
*
|
1991-06-10 |
1994-12-20 |
Alberta Research Council |
Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
|
|
KR950014915B1
(ko)
*
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
|
US5281698A
(en)
*
|
1991-07-23 |
1994-01-25 |
Cetus Oncology Corporation |
Preparation of an activated polymer ester for protein conjugation
|
|
US6319695B1
(en)
*
|
1991-10-15 |
2001-11-20 |
The Scripps Research Insitute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
|
IT1260468B
(it)
|
1992-01-29 |
1996-04-09 |
|
Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
|
|
US5858751A
(en)
*
|
1992-03-09 |
1999-01-12 |
The Regents Of The University Of California |
Compositions and methods for producing sialyltransferases
|
|
US5962294A
(en)
*
|
1992-03-09 |
1999-10-05 |
The Regents Of The University Of California |
Compositions and methods for the identification and synthesis of sialyltransferases
|
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
JPH08503125A
(ja)
*
|
1992-08-07 |
1996-04-09 |
プロジェニクス・ファーマスーティカルス・インコーポレーテッド |
非ペプチジル成分と複合化されたＣＤ４−ガンマ２およびＣＤ４−ＩｇＧ２免疫複合体、並びにその使用
|
|
WO1994004193A1
(en)
|
1992-08-21 |
1994-03-03 |
Enzon, Inc. |
Novel attachment of polyalkylene oxides to bio-effecting substances
|
|
AU5098193A
(en)
|
1992-09-01 |
1994-03-29 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
|
AU6029594A
(en)
|
1993-01-15 |
1994-08-15 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
|
US5202413A
(en)
|
1993-02-16 |
1993-04-13 |
E. I. Du Pont De Nemours And Company |
Alternating (ABA)N polylactide block copolymers
|
|
SG49117A1
(en)
|
1993-03-29 |
1998-05-18 |
Kyowa Hakko Kogyo Kk |
Alfa -1, 3-fucosyltransferase
|
|
US5374541A
(en)
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
|
AU6663294A
(en)
|
1993-05-14 |
1994-12-12 |
Upjohn Company, The |
Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
|
|
AU7097094A
(en)
|
1993-06-01 |
1994-12-20 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
|
US5621039A
(en)
*
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
|
DE4325317C2
(de)
|
1993-07-29 |
1998-05-20 |
Univ Dresden Tech |
Verfahren zur radioaktiven Markierung von Immunglobulinen
|
|
JPH0770195A
(ja)
*
|
1993-08-23 |
1995-03-14 |
Yutaka Mizushima |
糖修飾インターフェロン
|
|
US5874075A
(en)
*
|
1993-10-06 |
1999-02-23 |
Amgen Inc. |
Stable protein: phospholipid compositions and methods
|
|
US5643575A
(en)
*
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5446090A
(en)
*
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
US5443953A
(en)
*
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
|
US5369017A
(en)
*
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
|
US5837458A
(en)
*
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US5605793A
(en)
*
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US5492841A
(en)
*
|
1994-02-18 |
1996-02-20 |
E. I. Du Pont De Nemours And Company |
Quaternary ammonium immunogenic conjugates and immunoassay reagents
|
|
US5432059A
(en)
*
|
1994-04-01 |
1995-07-11 |
Specialty Laboratories, Inc. |
Assay for glycosylation deficiency disorders
|
|
US5646113A
(en)
*
|
1994-04-07 |
1997-07-08 |
Genentech, Inc. |
Treatment of partial growth hormone insensitivity syndrome
|
|
GB9408717D0
(en)
|
1994-05-03 |
1994-06-22 |
Biotech & Biolog Scien Res |
DNA sequences
|
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
IL116730A0
(en)
|
1995-01-13 |
1996-05-14 |
Amgen Inc |
Chemically modified interferon
|
|
US5876980A
(en)
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
|
US6030815A
(en)
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
|
US5922577A
(en)
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
|
US5728554A
(en)
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
|
WO1996036357A1
(en)
|
1995-05-15 |
1996-11-21 |
Bona Constantin A |
Carbohydrate-mediated coupling of peptides to immunoglobulins
|
|
US6015555A
(en)
*
|
1995-05-19 |
2000-01-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
|
US5824864A
(en)
*
|
1995-05-25 |
1998-10-20 |
Pioneer Hi-Bred International, Inc. |
Maize gene and protein for insect control
|
|
US5858752A
(en)
|
1995-06-07 |
1999-01-12 |
The General Hospital Corporation |
Fucosyltransferase genes and uses thereof
|
|
US6251864B1
(en)
*
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
|
US6127153A
(en)
*
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
|
US5672662A
(en)
*
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
US5770420A
(en)
*
|
1995-09-08 |
1998-06-23 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
|
JP3628333B2
(ja)
*
|
1995-09-21 |
2005-03-09 |
ジェネンテック インコーポレーテッド |
ヒト成長ホルモン変異体
|
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
|
US5716812A
(en)
|
1995-12-12 |
1998-02-10 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
|
EP0888377B1
(en)
|
1996-03-08 |
2007-12-12 |
The Regents Of The University Of Michigan |
MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
|
|
EP0953354A4
(en)
*
|
1996-08-13 |
2002-10-23 |
Fujisawa Pharmaceutical Co |
HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
HUP0001634A2
(hu)
*
|
1996-10-10 |
2000-09-28 |
Cytel Corporation |
Szénhidrátok tisztítása ultraszűréssel, fordított ozmózissal és nanoszűréssel
|
|
SK283518B6
(sk)
|
1996-10-15 |
2003-08-05 |
The Liposome Company, Inc. |
Konjugát peptidu s lipidom, lipozóm, farmaceutický prostriedok a použitie
|
|
CN1244214A
(zh)
*
|
1996-11-08 |
2000-02-09 |
尼澳斯技术股份有限公司 |
改进的表达载体
|
|
ES2218806T3
(es)
*
|
1997-01-16 |
2004-11-16 |
Neose Technologies, Inc. |
Sialilacion practica in vitro de glicoproteinas recombinantes.
|
|
US5945314A
(en)
*
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
|
JP2002505574A
(ja)
|
1997-04-30 |
2002-02-19 |
エンゾン，インコーポレイテッド |
ポリアルキレンオキシド修飾された単鎖ポリペプチド
|
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
|
US6075134A
(en)
*
|
1997-05-15 |
2000-06-13 |
The Regents Of The University Of California |
Glycoconjugates and methods
|
|
US6399337B1
(en)
|
1997-06-06 |
2002-06-04 |
The Governors Of The University Of Alberta |
α1,3-fucosyltransferase
|
|
US20030027257A1
(en)
*
|
1997-08-21 |
2003-02-06 |
University Technologies International, Inc. |
Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
|
|
JP3863265B2
(ja)
*
|
1997-10-16 |
2006-12-27 |
富士通株式会社 |
光受信器およびクロック抽出回路
|
|
AU744303B2
(en)
|
1997-12-01 |
2002-02-21 |
Neose Technologies, Inc. |
Enzymatic synthesis of gangliosides
|
|
EP0924298A1
(en)
|
1997-12-18 |
1999-06-23 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Protein expression in baculovirus vector expression systems
|
|
JP3786832B2
(ja)
|
1998-01-07 |
2006-06-14 |
デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム |
分解性のヘテロ二官能性ポリ（エチレングリコール）アクリレート及びそれから誘導されるゲル及び複合体
|
|
ATE268609T1
(de)
|
1998-03-12 |
2004-06-15 |
Nektar Therapeutics Al Corp |
Polyethylenglycolderivate mit benachbarten reaktiven gruppen
|
|
WO1999048515A1
(en)
|
1998-03-25 |
1999-09-30 |
Sloan-Kettering Institute For Cancer Research |
Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
|
|
AU760381B2
(en)
|
1998-04-28 |
2003-05-15 |
Laboratoires Serono Sa |
PEG-LHRH analog conjugates
|
|
US20030166525A1
(en)
|
1998-07-23 |
2003-09-04 |
Hoffmann James Arthur |
FSH Formulation
|
|
HU229888B1
(en)
|
1998-10-16 |
2014-11-28 |
Biogen Idec Ma Inc Cambridge |
Polymer conjugates of interferon betha-1a and uses
|
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
WO2000026354A1
(en)
|
1998-10-30 |
2000-05-11 |
Novozymes A/S |
Glycosylated proteins having reduced allergenicity
|
|
AU772112B2
(en)
|
1998-11-13 |
2004-04-08 |
Henrick Clausen |
UDP-galactose: beta-(N)-acetyl-glucosamine beta1,3galactosyltransferases, beta3gal-t5
|
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
|
MXPA01004982A
(es)
|
1998-11-18 |
2004-09-27 |
Neose Technologies Inc |
Manufactura de bajo costo de oligosacaridos.
|
|
US6465220B1
(en)
*
|
1998-12-21 |
2002-10-15 |
Glycozym Aps |
Glycosylation using GalNac-T4 transferase
|
|
US6949372B2
(en)
|
1999-03-02 |
2005-09-27 |
The Johns Hopkins University |
Engineering intracellular sialylation pathways
|
|
CA2370469A1
(en)
|
1999-04-22 |
2000-11-02 |
Astrazeneca Ab |
Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
|
|
JO2291B1
(en)
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
|
US6261805B1
(en)
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
|
AU6357900A
(en)
|
1999-07-20 |
2001-02-05 |
Amgen, Inc. |
Hyaluronic acid-protein conjugates, pharmaceutical compositions and related methods
|
|
JP4451514B2
(ja)
|
1999-08-24 |
2010-04-14 |
財団法人化学及血清療法研究所 |
血液凝固第ｖｉｉ因子改変体
|
|
US6534300B1
(en)
*
|
1999-09-14 |
2003-03-18 |
Genzyme Glycobiology Research Institute, Inc. |
Methods for producing highly phosphorylated lysosomal hydrolases
|
|
AUPQ296799A0
(en)
|
1999-09-20 |
1999-10-14 |
Unisearch Limited |
A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
|
|
US6716626B1
(en)
|
1999-11-18 |
2004-04-06 |
Chiron Corporation |
Human FGF-21 nucleic acids
|
|
JP5209161B2
(ja)
|
1999-12-02 |
2013-06-12 |
ザイモジェネティクス， インコーポレイテッド |
腺維芽細胞成長受容体−３又は−２を発現する細胞を標的化するための方法
|
|
US6348558B1
(en)
*
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
US6376604B2
(en)
|
1999-12-22 |
2002-04-23 |
Shearwater Corporation |
Method for the preparation of 1-benzotriazolylcarbonate esters of poly(ethylene glycol)
|
|
AU2223401A
(en)
|
1999-12-24 |
2001-07-09 |
Kyowa Hakko Kogyo Co. Ltd. |
Branched polyalkylene glycols
|
|
AU2352201A
(en)
|
1999-12-30 |
2001-07-16 |
Maxygen Aps |
Improved lysosomal enzymes and lysosomal enzyme activators
|
|
US6555660B2
(en)
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
|
SK11672002A3
(sk)
|
2000-01-10 |
2002-12-03 |
Maxygen Holdings Ltd. |
Polypeptidový konjugát, spôsob jeho výroby, farmaceutický prostriedok s jeho obsahom a jeho použitie
|
|
US6646110B2
(en)
*
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
|
PL204285B1
(pl)
|
2000-02-11 |
2009-12-31 |
Bayer Healthcare Llc |
Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
|
|
WO2001058493A1
(en)
|
2000-02-11 |
2001-08-16 |
Maxygen Aps |
Conjugates of follicle stimulating hormones
|
|
AU2001232337A1
(en)
|
2000-02-18 |
2001-08-27 |
Kanagawa Academy Of Science And Technology |
Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
|
|
WO2001068565A2
(en)
|
2000-03-16 |
2001-09-20 |
The Regents Of The University Of California |
Chemoselective ligation by use of a phosphine
|
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
EP1282693B1
(en)
|
2000-05-03 |
2010-10-20 |
Novo Nordisk Health Care AG |
Human coagulation factor vii variants
|
|
US7338932B2
(en)
|
2000-05-11 |
2008-03-04 |
Glycozym Aps |
Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
|
|
EP1285072A2
(en)
|
2000-05-12 |
2003-02-26 |
Neose Technologies, Inc. |
In vitro fucosylation recombinant glycopeptides
|
|
ATE291436T2
(de)
|
2000-05-15 |
2005-04-15 |
Hoffmann La Roche |
Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
|
|
AU2001276842B2
(en)
*
|
2000-06-28 |
2007-04-26 |
Glycofi, Inc. |
Methods for producing modified glycoproteins
|
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
|
JP2004504016A
(ja)
|
2000-06-30 |
2004-02-12 |
マキシゲン・エイピーエス |
ペプチド拡張されたグリコシル化ポリペプチド
|
|
KR100396983B1
(ko)
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
|
WO2002013873A2
(en)
|
2000-08-17 |
2002-02-21 |
Synapse Technologies, Inc. |
P97-active agent conjugates and their methods of use
|
|
WO2002013843A2
(en)
|
2000-08-17 |
2002-02-21 |
University Of British Columbia |
Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
|
|
AU9165201A
(en)
|
2000-10-02 |
2002-04-15 |
Novo Nordisk As |
Factor vii glycoforms
|
|
WO2002044196A1
(en)
|
2000-11-28 |
2002-06-06 |
University Of Massachusetts |
Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of rna
|
|
MXPA03005406A
(es)
*
|
2000-12-20 |
2003-09-25 |
Hoffmann La Roche |
Conjugados de eritropoyetina.
|
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
JP2004534523A
(ja)
|
2001-02-27 |
2004-11-18 |
マキシゲン・エイピーエス |
新規なインターフェロンβ様分子
|
|
US7235638B2
(en)
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
|
CZ20032454A3
(en)
|
2001-03-22 |
2004-03-17 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivative
|
|
CN1318105C
(zh)
*
|
2001-04-02 |
2007-05-30 |
霍克研究基金会 |
顺应性的无气囊导管
|
|
US20020168323A1
(en)
*
|
2001-05-11 |
2002-11-14 |
Igor Gonda |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
|
WO2002092619A2
(en)
|
2001-05-14 |
2002-11-21 |
The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
|
KR100453877B1
(ko)
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
|
NZ531093A
(en)
|
2001-08-17 |
2007-12-21 |
Neose Technologies Inc |
Chemo-enzymatic synthesis of sialylated oligosaccharides
|
|
JP2005527467A
(ja)
|
2001-08-29 |
2005-09-15 |
ネオーズ テクノロジーズ， インコーポレイテッド |
新規な合成ガングリオシド誘導体およびその組成物
|
|
US7052868B2
(en)
|
2001-09-27 |
2006-05-30 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
ES2376694T3
(es)
|
2001-09-27 |
2012-03-16 |
Novo Nordisk Health Care Ag |
Polipã‰ptidos del factor vii de coagulaciã“n humano.
|
|
US7399613B2
(en)
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
EP2305312B1
(en)
|
2001-10-10 |
2015-03-04 |
ratiopharm GmbH |
Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)
|
|
US7696163B2
(en)
*
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7297511B2
(en)
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
|
US7795210B2
(en)
*
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
US6784154B2
(en)
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
|
AU2002336919A1
(en)
|
2001-11-02 |
2003-05-12 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
|
US7368108B2
(en)
*
|
2001-11-28 |
2008-05-06 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
|
US7473680B2
(en)
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
|
US20060035224A1
(en)
|
2002-03-21 |
2006-02-16 |
Johansen Jack T |
Purification methods for oligonucleotides and their analogs
|
|
US6786755B2
(en)
*
|
2002-03-27 |
2004-09-07 |
Molex Incorporated |
Differential signal connector assembly with improved retention capabilities
|
|
ATE503498T1
(de)
|
2002-06-21 |
2011-04-15 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
|
DE10232916B4
(de)
|
2002-07-19 |
2008-08-07 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zum Charakterisieren eines Informationssignals
|
|
WO2004009838A2
(en)
|
2002-07-23 |
2004-01-29 |
Neose Technologies, Inc. |
H. Pylori FUCOSYLTRANSFERASES
|
|
WO2004021993A2
(en)
*
|
2002-09-05 |
2004-03-18 |
The General Hospital Corporation |
Modified asialo-interferons and uses thereof
|
|
CA2497794A1
(en)
|
2002-09-06 |
2004-03-18 |
Bayer Pharmaceuticals Corporation |
Modified glp-1 receptor agonists and their pharmacological methods of use
|
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
CA2502162C
(en)
|
2002-09-30 |
2014-04-15 |
Bayer Healthcare Llc |
Fvii or fviia variants having increased clotting activity
|
|
AU2003275952A1
(en)
|
2002-11-08 |
2004-06-07 |
Glycozym Aps |
Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use
|
|
JP4412461B2
(ja)
|
2002-11-20 |
2010-02-10 |
日油株式会社 |
修飾された生体関連物質、その製造方法および中間体
|
|
US20050064540A1
(en)
|
2002-11-27 |
2005-03-24 |
Defrees Shawn Ph.D |
Glycoprotein remodeling using endoglycanases
|
|
EP1424344A1
(en)
|
2002-11-29 |
2004-06-02 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Modified cDNA factor VIII and its derivates
|
|
DK1428878T3
(da)
|
2002-12-13 |
2008-12-08 |
Bioceuticals Arzneimittel Ag |
Fremgangsmåde til produktion og oprensning af erythropoietin
|
|
RS20050502A
(sr)
|
2002-12-26 |
2007-08-03 |
Mountain View Pharmaceuticals Inc., |
Polimerni konjugati interferona- beta sa povećanom biološkom aktivnošću
|
|
US7041635B2
(en)
|
2003-01-28 |
2006-05-09 |
In2Gen Co., Ltd. |
Factor VIII polypeptide
|
|
CA2788505C
(en)
|
2003-02-26 |
2018-09-04 |
Nektar Therapeutics |
Polymer-factor viii moiety conjugates
|
|
CN102212019B
(zh)
*
|
2003-03-14 |
2015-05-27 |
蔚所番有限公司 |
支化水溶性聚合物及其缀合物
|
|
EP1603954A4
(en)
|
2003-03-18 |
2006-04-12 |
Neose Technologies Inc |
ACTIVATED FORMS OF WATER SOLUBLE POLYMERS
|
|
EA009366B1
(ru)
|
2003-03-19 |
2007-12-28 |
Эли Лилли Энд Компани |
Связанные с полиэтиленгликолем соединения гпп-1
|
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
WO2004091499A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
|
US7718363B2
(en)
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
|
MXPA05011832A
(es)
|
2003-05-09 |
2006-02-17 |
Neose Technologies Inc |
Composiciones y metodos para la preparacion de mutantes de glicosilacion de la hormona de crecimiento humano.
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
|
CN1882355A
(zh)
|
2003-09-09 |
2006-12-20 |
沃伦药品公司 |
保持内源性促红细胞生成素组织保护活性的长效促红细胞生成素
|
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
WO2005072371A2
(en)
|
2004-01-26 |
2005-08-11 |
Neose Technologies, Inc. |
Branched polymeric sugars and nucleotides thereof
|
|
AU2004293103C1
(en)
|
2003-11-24 |
2010-12-02 |
Ratiopharm Gmbh |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
|
US20080318850A1
(en)
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
|
EP1694274B1
(en)
|
2003-12-03 |
2013-04-24 |
BioGeneriX AG |
Glycopegylated granulocyte colony stimulating factor
|
|
EP1694315A4
(en)
*
|
2003-12-03 |
2009-10-28 |
Novo Nordisk As |
FACTOR IX GLYCOPEGYL
|
|
JP2007515410A
(ja)
*
|
2003-12-03 |
2007-06-14 |
ネオス テクノロジーズ インコーポレイテッド |
ＧｌｙｃｏＰＥＧ化卵胞刺激ホルモン
|
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
US8361961B2
(en)
|
2004-01-08 |
2013-01-29 |
Biogenerix Ag |
O-linked glycosylation of peptides
|
|
WO2005067601A2
(en)
|
2004-01-09 |
2005-07-28 |
Neose Technologies, Inc. |
Vectors for recombinant protein expression in e.coli
|
|
US20070105770A1
(en)
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
|
JP2007531715A
(ja)
|
2004-03-17 |
2007-11-08 |
イーライ リリー アンド カンパニー |
グリコール結合ｆｇｆ−２１化合物
|
|
EP1745141B2
(en)
|
2004-05-04 |
2019-09-25 |
Novo Nordisk Health Care AG |
O-linked glycoforms of faktor vii and method to manufacture them
|
|
US20070037966A1
(en)
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
|
WO2005121331A2
(en)
|
2004-06-03 |
2005-12-22 |
Neose Technologies, Inc. |
Truncated galnact2 polypeptides and nucleic acids
|
|
WO2005121332A2
(en)
|
2004-06-03 |
2005-12-22 |
Neose Technologies, Inc. |
Truncated st6galnaci polypeptides and nucleic acids
|
|
WO2006014466A2
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Novel carbamylated epo and method for its production
|
|
AU2005270092A1
(en)
|
2004-07-02 |
2006-02-09 |
Cerami, Anthony |
Method of producing fully carbamylated erythropoietin
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
WO2006020372A2
(en)
|
2004-07-23 |
2006-02-23 |
Neose Technologies, Inc. |
Enzymatic modification of glycopeptides
|
|
US20060024286A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Paul Glidden |
Variants of tRNA synthetase fragments and uses thereof
|
|
WO2006013202A2
(en)
|
2004-08-02 |
2006-02-09 |
Novo Nordisk Health Care Ag |
Conjugation of fvii
|
|
EP1799249A2
(en)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
|
EP1797192A1
(en)
|
2004-09-29 |
2007-06-20 |
Novo Nordisk Health Care AG |
Modified proteins
|
|
EP1814573B1
(en)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
WO2006066258A2
(en)
|
2004-12-17 |
2006-06-22 |
Neose Technologies, Inc. |
Lipoconjugation of peptides
|
|
US20100009902A1
(en)
|
2005-01-06 |
2010-01-14 |
Neose Technologies, Inc. |
Glycoconjugation Using Saccharyl Fragments
|
|
CA2593682C
(en)
|
2005-01-10 |
2016-03-22 |
Neose Technologies, Inc. |
Glycopegylated granulocyte colony stimulating factor
|
|
WO2006078645A2
(en)
|
2005-01-19 |
2006-07-27 |
Neose Technologies, Inc. |
Heterologous polypeptide expression using low multiplicity of infection of viruses
|
|
US8137928B2
(en)
|
2005-03-24 |
2012-03-20 |
BioGeneriX |
Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
|
|
EP1866427A4
(en)
|
2005-03-30 |
2010-09-01 |
Novo Nordisk As |
METHOD OF MANUFACTURING PEPTIDES PRODUCED IN INSECT CELL LINES
|
|
EP1871795A4
(en)
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
|
|
DK1888761T3
(da)
|
2005-05-11 |
2010-11-01 |
Eth Zuerich |
Rekombinante N-glycosylerede proteiner fra prokaryote celler
|
|
EP1888098A2
(en)
|
2005-05-25 |
2008-02-20 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin formulations
|
|
US20110003744A1
(en)
|
2005-05-25 |
2011-01-06 |
Novo Nordisk A/S |
Glycopegylated Erythropoietin Formulations
|
|
JP5335422B2
(ja)
|
2005-06-17 |
2013-11-06 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
少なくとも１つの非天然のシステインを含んでいる操作されたタンパク質の選択的な還元および誘導体化
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US20090305967A1
(en)
|
2005-08-19 |
2009-12-10 |
Novo Nordisk A/S |
Glycopegylated factor vii and factor viia
|
|
JP5690047B2
(ja)
|
2005-09-14 |
2015-03-25 |
ノボ ノルディスク ヘルス ケア アーゲー |
ヒト凝固第ｖｉｉ因子ポリペプチド
|
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
|
JP4851182B2
(ja)
*
|
2005-12-28 |
2012-01-11 |
ルネサスエレクトロニクス株式会社 |
マイクロコンピュータ、マイクロコンピュータに対するプログラム書込み方法、及び書込み処理システム
|
|
DE202006020194U1
(de)
|
2006-03-01 |
2007-12-06 |
Bioceuticals Arzneimittel Ag |
G-CSF-Flüssigformulierung
|
|
KR20090013816A
(ko)
|
2006-05-24 |
2009-02-05 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
연장된 생체내 반감기를 갖는 인자 ⅸ 유사체
|
|
US9187532B2
(en)
|
2006-07-21 |
2015-11-17 |
Novo Nordisk A/S |
Glycosylation of peptides via O-linked glycosylation sequences
|
|
ITMI20061624A1
(it)
|
2006-08-11 |
2008-02-12 |
Bioker Srl |
Mono-coniugati sito-specifici di g-csf
|
|
EP2059527B1
(en)
|
2006-09-01 |
2014-12-03 |
Novo Nordisk Health Care AG |
Modified glycoproteins
|
|
US20100075375A1
(en)
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
|
CA2665480C
(en)
|
2006-10-04 |
2019-11-12 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
|
WO2008073620A2
(en)
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
|
CN101796063B
(zh)
|
2007-04-03 |
2017-03-22 |
拉蒂奥法姆有限责任公司 |
使用糖聚乙二醇化g‑csf的治疗方法
|
|
US20090053167A1
(en)
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
|
CN101778937A
(zh)
|
2007-06-04 |
2010-07-14 |
诺和诺德公司 |
使用n-乙酰葡糖胺转移酶的o-联糖基化
|
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
|
WO2009089396A2
(en)
|
2008-01-08 |
2009-07-16 |
Neose Technologies, Inc. |
Glycoconjugation of polypeptides using oligosaccharyltransferases
|